Huiwen Yan

1.8k citations
24 papers · 1.2k indexed · 1 hit paper · h-index 15
Topics
MicroRNA in disease regulation (3 papers)RNA modifications and cancer (3 papers)Angiogenesis and VEGF in Cancer (3 papers)
Partner nations
ChinaUnited States

In The Last Decade

Huiwen Yan

24 papers receiving 1.2k citations

Hit Papers

Non-coding RNA in cancer20212026202220242021100200300400

Peers

Huiwen Yan
Comparison fields: 5 of 86
  • Molecular Biology 870
  • Cancer Research 553
  • Oncology 196
  • Immunology 140
  • Pulmonary and Respiratory Medicine 91
Replace Moon-Kyoung Bae with:
Moon-Kyoung Bae South Korea
Yan Jin China
Nan Zhao China
Ming-Yang Wang Taiwan
Dana Napier United States
Lucia Cappabianca Italy
Fang Zhao China
Taidong Qiao China
Huahong Xie China
Claudio Raimondi United Kingdom
Huiwen Yan relative to Moon-Kyoung Bae South Korea Moon-Kyoung Bae's profile →
Citations per field
00.5×9.6×
Moon-Kyoung Bae · 1×
Citations per year

Countries citing papers authored by Huiwen Yan

Since Specialization
Citations

This map shows the geographic impact of Huiwen Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huiwen Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huiwen Yan more than expected).

Fields of papers citing papers by Huiwen Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huiwen Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huiwen Yan. The network helps show where Huiwen Yan may publish in the future.

Co-authorship network of co-authors of Huiwen Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Huiwen Yan. A scholar is included among the top collaborators of Huiwen Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huiwen Yan. Huiwen Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 19
2 3
3 7
4 9
5 14
6 33
7 7
8 89
9 99
10 19
11
Non-coding RNA in cancerbreakdown →
417
12 11
13 52
14 10
15 29
16 29
17 21
18 103
19 18
20 45

About Huiwen Yan

Huiwen Yan is a scholar working on Cancer Research, Immunology and Allergy and Biotechnology, having authored 24 papers that have together received 1.2k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (3 papers), RNA modifications and cancer (3 papers) and Angiogenesis and VEGF in Cancer (3 papers). The work is most often cited by research in Cancer Research (553 citations), Molecular Biology (870 citations) and Immunology and Allergy (56 citations). Huiwen Yan has collaborated with scholars based in China and United States. Frequent co-authors include Pengcheng Bu, Xiyun Yan, Jing Feng, Yongting Luo, Zhongde Ye, Hongxia Duan, Liwen Zhang, Feng Liu, Qiqun Zeng and Jie Zhuang. Their work appears in journals such as Journal of Clinical Investigation, Blood and Cell Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026